Literature DB >> 10092826

Amplification of the antibody response by C3b complexed to antigen through an ester link.

M B Villiers1, C L Villiers, A M Laharie, P N Marche.   

Abstract

Complement C3 has been described as playing an important role in the cell-mediated immune response. C3b has the capacity to covalently bind Ag and then to stimulate in vitro Ag presentation to T lymphocytes. To verify this observation in vivo, we prepared and purified covalent human C3b-Ag complexes using lysozyme (HEL) as Ag. The characterization of these HEL-C3b complexes indicates that they are representative of those susceptible to be generated in physiological conditions. Mice were immunized with 0.1 to 0.6 microgram of either free HEL, HEL + C3b, HEL-C3b, or HEL + CFA. Response was assessed after two i.p. injections by quantification of specific Ab production. Immunization with either HEL-C3b complexes or HEL + CFA leads to anti-HEL IgG production whereas free HEL or HEL + C3b was ineffective. Either HEL-C3b or HEL + CFA immunizations led to a similar Ig subclass patterns, including IgG1, IgG2a, IgA, and IgM. Our experiments provide the first evidence for modulation of specific Ab response by C3b when it is bound to Ag through a physiological-like link. Taken together with previous data concerning Ab response following recombinant HEL-C3d immunization, cellular events such as processing of C3b-Ag by APC and recognition by T lymphocytes, this present result underlines the importance of C3b and its fragments in stimulation of the immune system, through the multiplicity and complementarity of its interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092826

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Evolution of complement as an effector system in innate and adaptive immunity.

Authors:  J Oriol Sunyer; Hani Boshra; Gema Lorenzo; David Parra; Bruce Freedman; Nina Bosch
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  Materials engineering for immunomodulation.

Authors:  Jeffrey A Hubbell; Susan N Thomas; Melody A Swartz
Journal:  Nature       Date:  2009-11-26       Impact factor: 49.962

3.  Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide.

Authors:  S T Test; J Mitsuyoshi; C C Connolly; A H Lucas
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.

Authors:  Huiying Fan; Tiezhu Tong; Huanchun Chen; Aizhen Guo
Journal:  Virus Genes       Date:  2007-05-12       Impact factor: 2.332

5.  Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus.

Authors:  Lingshu Wang; J Oriol Sunyer; Leonard J Bello
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Chemical labelling of active serum thioester proteins for quantification.

Authors:  Lotta Holm; Gareth L Ackland; Mark R Edwards; Ross A Breckenridge; Robert B Sim; John Offer
Journal:  Immunobiology       Date:  2011-07-23       Impact factor: 3.144

7.  Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement.

Authors:  Benjamin Charvet; Josephine M Reynaud; Geraldine Gourru-Lesimple; Hervé Perron; Patrice N Marche; Branka Horvat
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

Review 8.  The role of the complement system in kidney glomerular capillary thrombosis.

Authors:  Yoko Yoshida; Hiroshi Nishi
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

9.  Commandeering a biological pathway using aptamer-derived molecular adaptors.

Authors:  Prabhat K Mallik; Kimi Nishikawa; Albert J T Millis; Hua Shi
Journal:  Nucleic Acids Res       Date:  2010-01-06       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.